83
29
Growth Score 83 in past quarter
-4 pts
Heat Score 29 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3026830
CAF-DCF specializes in commercializing plasma-derived medicines for severe and often rare diseases.
About the Company
CAF-DCF is a company that specializes in the commercialization of plasma-derived medicines. The company's primary focus is on providing essential medications for the treatment of patients suffering from severe and often rare diseases. The medicines are primarily derived from plasma taken from volunteer, unpaid donors at Belgian blood
transfusion centres. The company has a long-term expertise in life-saving products for rare diseases, making it a crucial player in the healthcare industry.